Acta Scientific Pharmacology

Research Article Volume 3 Issue 9

Assessment of Quality of Life, Drug-drug Interactions and Associated Complications Among Diabetic Patient in a Tertiary Care Hospital

Akhila TR1*, Aswathy Bennit1, Jitha Raj1, Nizamudheen Nasar Kovvaprath1 and Sujith S Nair2

1Doctor of Pharmacy Intern, Crescent College of Pharmaceutical Sciences, Kerala University of Health Sciences, India
2Professor, Crescent College of Pharmaceutical Sciences, Kannur, Kerala, India

*Corresponding Author: Akhila TR, Doctor of Pharmacy Intern, Crescent College of Pharmaceutical Sciences, Kerala University of Health Sciences, India.

Received: June 20, 2022 Published: August 08, 2022

Abstract

The aim of study is to assess quality of life, drug-drug interaction and associated complication among diabetic patient in tertiary care hospital.

Materials and Methods: A Cross sectional study of six month duration was conducted. Data collected were documented, analysed and entered into Microsoft Excel. Statistical analysis was done by using Microsoft Excel.

Results: 120 patients were included in our study and among them 65 were males and 55 were females. The overall mean score of QoL in diabetic patients was 55.32, indicating a moderate to low QoL in them. From the total drugs prescribed, 143 interactions were found out and among this pharmacodynamic interactions (58.3%) were found to be more than pharmacokinetic interactions (45.8%). Most frequent complication was found to be hypertension (92.5%), followed by retinopathy (41.6%), CAD (39.1%), nephropathy (24.1%), foot ulcer (15.8%), neuropathy (15%) and stroke (9.16%).

Conclusion: Our study highlights the quality of life in Diabetic patient. The occurrence of Type 2 diabetes was more in case of males than female. Smoking is a risk factor for type 2 diabetes. Our study shows that the type 2 diabetes patients have low to moderate QoL. Majority of the patients had hypertension associated as complication.

Keywords: Type 2 Diabetes Mellitus; Quality of Life (QOL); WHOQOL-BREF Questionnaire; Pharmacokinetics; Pharmacodynamics

References

  1. Saher Mahmood Jwad and HawraaYousif AL-Fatlawi. “The Effect of Diabetes on the Possessions of Blood and Vessels”. Journal of Advances in Pharmacy Practices1 (2022): 15-20.
  2. Najjar ZSR., et al. “Assessment of 1.25 (OH). 2D3 levels and nephropathy stages in adult male patients with type-2 diabetes mellitus”. Journal of Critical Review13 (2020): 1667-1674.
  3. Sura Essam Mohammed Reda., et al. “Biomaterials and Green Chemical Compounds and their Health Effect”. Journal of Pharma and Drug Regulatory Affairs1 (2022): 50-58.
  4. Saher Mahmood Jwad and HawraaYousif AL-Fatlawi. “Diabetic Nephropathy and Its Effect on the Physiological Factors of The body”. Trends in Pharmaceuticals and Nanotechnology1 (2022): 24-30.
  5. Israa Majid Neamah and Saher Mahmood Jwad. “Chronic Complications of Diabetes and their Impact on the Patient”. Journal of Advances in Bio-pharmaceutics and Pharmacovigilance1 (2022): 31-35.
  6. Saher Mahmood Jwad and Israa Majid Neamah. “Hormonal and Genetic Influence of Diabetes Mellitus”. Journal of Pharmaceutical Quality Assurance and Quality Control 1 (2022): 22-26.

Citation

Citation: Akhila TR. “Assessment of Quality of Life, Drug-drug Interactions and Associated Complications Among Diabetic Patient in a Tertiary Care Hospital". Acta Scientific Pharmacology 3.9 (2022): 03-07.

Copyright

Copyright: © 2022 Akhila TR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US